+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Laryngeal Cancer Therapeutics Market 2024-2028

  • PDF Icon

    Report

  • 170 Pages
  • August 2024
  • Region: Global
  • TechNavio
  • ID: 5304719
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The laryngeal cancer therapeutics market is forecasted to grow by USD 648 million during 2023-2028, accelerating at a CAGR of 5.8% during the forecast period. The report on the laryngeal cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of laryngeal cancer, increasing number of reimbursement programs, and rising awareness and early detection of laryngeal cancer.

The laryngeal cancer therapeutics market is segmented as below:

By Type

  • Biologics
  • Small molecules

By Distribution Channel

  • Offline
  • Online

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advent of novel therapies as one of the prime reasons driving the laryngeal cancer therapeutics market growth during the next few years. Also, increasing prevalence of precision medicine and presence of novel therapies in pipeline for treatment will lead to sizable demand in the market.

The report on the laryngeal cancer therapeutics market covers the following areas:

  • Laryngeal cancer therapeutics market sizing
  • Laryngeal cancer therapeutics market forecast
  • Laryngeal cancer therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading laryngeal cancer therapeutics market vendors that include Accord Healthcare Ltd., Amgen Inc., AstraZeneca Plc, Athenex Inc., Bayer AG, Bristol Myers Squibb Co., Celldex Therapeutics Inc, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hangzhou Adlai Nortye Biopharma Co. Ltd., Hanmi Pharm Co. Ltd., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. Also, the laryngeal cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Laryngeal Cancer Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Laryngeal Cancer Therapeutics Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 Biologics - Market size and forecast 2023-2028
Chart on Biologics - Market size and forecast 2023-2028 ($ million)
Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
Chart on Biologics - Year-over-year growth 2023-2028 (%)
Data Table on Biologics - Year-over-year growth 2023-2028 (%)
6.4 Small molecules - Market size and forecast 2023-2028
Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
Chart on Small molecules - Year-over-year growth 2023-2028 (%)
Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2023-2028
Chart on Offline - Market size and forecast 2023-2028 ($ million)
Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Chart on Offline - Year-over-year growth 2023-2028 (%)
Data Table on Offline - Year-over-year growth 2023-2028 (%)
7.4 Online - Market size and forecast 2023-2028
Chart on Online - Market size and forecast 2023-2028 ($ million)
Data Table on Online - Market size and forecast 2023-2028 ($ million)
Chart on Online - Year-over-year growth 2023-2028 (%)
Data Table on Online - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product/Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.4 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product/Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.5 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product/Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.7 Celldex Therapeutics Inc
Celldex Therapeutics Inc - Overview
Celldex Therapeutics Inc - Product/Service
Celldex Therapeutics Inc - Key offerings
12.8 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product/Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.10 Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd. - Overview
Hangzhou Adlai Nortye Biopharma Co. Ltd. - Product/Service
Hangzhou Adlai Nortye Biopharma Co. Ltd. - Key offerings
12.11 Hanmi Pharm Co. Ltd.
Hanmi Pharm Co. Ltd. - Overview
Hanmi Pharm Co. Ltd. - Product/Service
Hanmi Pharm Co. Ltd. - Key offerings
12.12 Hikma Pharmaceuticals Plc
Hikma Pharmaceuticals Plc - Overview
Hikma Pharmaceuticals Plc - Business segments
Hikma Pharmaceuticals Plc - Key news
Hikma Pharmaceuticals Plc - Key offerings
Hikma Pharmaceuticals Plc - Segment focus
12.13 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.14 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product/Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.15 Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc. - Overview
Regeneron Pharmaceuticals Inc. - Product/Service
Regeneron Pharmaceuticals Inc. - Key offerings
12.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.17 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product/Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Laryngeal Cancer Therapeutics Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Type - Market share 2023-2028 (%)
Exhibits 33: Data Table on Type - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Type
Exhibits 35: Data Table on Comparison by Type
Exhibits 36: Chart on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Small molecules - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
Exhibits 44: Market opportunity by Type ($ million)
Exhibits 45: Data Table on Market opportunity by Type ($ million)
Exhibits 46: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 47: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 48: Chart on Comparison by Distribution Channel
Exhibits 49: Data Table on Comparison by Distribution Channel
Exhibits 50: Chart on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits 52: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibits 53: Data Table on Offline - Year-over-year growth 2023-2028 (%)
Exhibits 54: Chart on Online - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Data Table on Online - Market size and forecast 2023-2028 ($ million)
Exhibits 56: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits 57: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits 58: Market opportunity by Distribution Channel ($ million)
Exhibits 59: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 61: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 63: Chart on Geographic comparison
Exhibits 64: Data Table on Geographic comparison
Exhibits 65: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 101: Market opportunity By Geographical Landscape ($ million)
Exhibits 102: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 103: Impact of drivers and challenges in 2023 and 2028
Exhibits 104: Overview on criticality of inputs and factors of differentiation
Exhibits 105: Overview on factors of disruption
Exhibits 106: Impact of key risks on business
Exhibits 107: Companies covered
Exhibits 108: Matrix on companies position and classification
Exhibits 109: Amgen Inc. - Overview
Exhibits 110: Amgen Inc. - Product/Service
Exhibits 111: Amgen Inc. - Key news
Exhibits 112: Amgen Inc. - Key offerings
Exhibits 113: AstraZeneca Plc - Overview
Exhibits 114: AstraZeneca Plc - Product/Service
Exhibits 115: AstraZeneca Plc - Key news
Exhibits 116: AstraZeneca Plc - Key offerings
Exhibits 117: Bayer AG - Overview
Exhibits 118: Bayer AG - Business segments
Exhibits 119: Bayer AG - Key news
Exhibits 120: Bayer AG - Key offerings
Exhibits 121: Bayer AG - Segment focus
Exhibits 122: Bristol Myers Squibb Co. - Overview
Exhibits 123: Bristol Myers Squibb Co. - Product/Service
Exhibits 124: Bristol Myers Squibb Co. - Key news
Exhibits 125: Bristol Myers Squibb Co. - Key offerings
Exhibits 126: Celldex Therapeutics Inc - Overview
Exhibits 127: Celldex Therapeutics Inc - Product/Service
Exhibits 128: Celldex Therapeutics Inc - Key offerings
Exhibits 129: Eli Lilly and Co. - Overview
Exhibits 130: Eli Lilly and Co. - Product/Service
Exhibits 131: Eli Lilly and Co. - Key news
Exhibits 132: Eli Lilly and Co. - Key offerings
Exhibits 133: F. Hoffmann La Roche Ltd. - Overview
Exhibits 134: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 135: F. Hoffmann La Roche Ltd. - Key news
Exhibits 136: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 137: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 138: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Overview
Exhibits 139: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Product/Service
Exhibits 140: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Key offerings
Exhibits 141: Hanmi Pharm Co. Ltd. - Overview
Exhibits 142: Hanmi Pharm Co. Ltd. - Product/Service
Exhibits 143: Hanmi Pharm Co. Ltd. - Key offerings
Exhibits 144: Hikma Pharmaceuticals Plc - Overview
Exhibits 145: Hikma Pharmaceuticals Plc - Business segments
Exhibits 146: Hikma Pharmaceuticals Plc - Key news
Exhibits 147: Hikma Pharmaceuticals Plc - Key offerings
Exhibits 148: Hikma Pharmaceuticals Plc - Segment focus
Exhibits 149: Merck and Co. Inc. - Overview
Exhibits 150: Merck and Co. Inc. - Business segments
Exhibits 151: Merck and Co. Inc. - Key news
Exhibits 152: Merck and Co. Inc. - Key offerings
Exhibits 153: Merck and Co. Inc. - Segment focus
Exhibits 154: Pfizer Inc. - Overview
Exhibits 155: Pfizer Inc. - Product/Service
Exhibits 156: Pfizer Inc. - Key news
Exhibits 157: Pfizer Inc. - Key offerings
Exhibits 158: Regeneron Pharmaceuticals Inc. - Overview
Exhibits 159: Regeneron Pharmaceuticals Inc. - Product/Service
Exhibits 160: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits 161: Sanofi SA - Overview
Exhibits 162: Sanofi SA - Business segments
Exhibits 163: Sanofi SA - Key news
Exhibits 164: Sanofi SA - Key offerings
Exhibits 165: Sanofi SA - Segment focus
Exhibits 166: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 167: Sun Pharmaceutical Industries Ltd. - Product/Service
Exhibits 168: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 169: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 170: Inclusions checklist
Exhibits 171: Exclusions checklist
Exhibits 172: Currency conversion rates for US$
Exhibits 173: Research methodology
Exhibits 174: Information sources
Exhibits 175: Data validation
Exhibits 176: Validation techniques employed for market sizing
Exhibits 177: Data synthesis
Exhibits 178: 360 degree market analysis
Exhibits 179: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global laryngeal cancer therapeutics market: Accord Healthcare Ltd., Amgen Inc., AstraZeneca Plc, Athenex Inc., Bayer AG, Bristol Myers Squibb Co., Celldex Therapeutics Inc, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hangzhou Adlai Nortye Biopharma Co. Ltd., Hanmi Pharm Co. Ltd., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advent of novel therapies."

According to the report, one of the major drivers for this market is the increasing prevalence of laryngeal cancer.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Accord Healthcare Ltd.
  • Amgen Inc.
  • AstraZeneca Plc
  • Athenex Inc.
  • Bayer AG
  • Bristol Myers Squibb Co.
  • Celldex Therapeutics Inc
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Fresenius SE and Co. KGaA
  • Hangzhou Adlai Nortye Biopharma Co. Ltd.
  • Hanmi Pharm Co. Ltd.
  • Hikma Pharmaceuticals Plc
  • Merck and Co. Inc.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.